Roles of microbiota-mediated hepatocarcinogenesis
Roles of microbiota-mediated hepatocarcinogenesis
批准号:
10925957
负责人:
Xin Wei Wang
金额:
$57.3万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
关键词:
AdenovirusesAnimal ModelAntigen PresentationAntiviral ResponseAreaB-LymphocytesBinding ProteinsCell DeathCentrosomeChromosomal InstabilityChronicComplexDevelopmentDockingEtiologyGene ExpressionGenesGenomic InstabilityGoalsHepatitisHepatitis B VirusHepatitis CHepatitis C virusHepatitis Delta VirusHepatocarcinogenesisHepatocyteHomeostasisHumanImmunityInflammationInterferonsLinkLiverMediatingMitosisMitotic spindleMolecularMolecular ProfilingNatural regenerationNuclear ExportOncogenicPathogenesisPathway interactionsPatientsPilot ProjectsPlayPrimary carcinoma of the liver cellsProteinsResearchRoleRunningSamplingSignal TransductionTissuesViral PhysiologyViral ProteinsViral hepatitisVirusVirus Diseasescarcinogenesischronic liver diseasemicrobiotanovelnucleocytoplasmic transportnucleophosminpreventran-binding protein 1toolvirus core
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Our previous results indicate that HBx contains a functional nuclear export signal motif that utilizes the Ran/Crm1 complex, a component essential in nucleocytoplasmic transport of many cellular and viral proteins. We demonstrated that HBx not only uses but also disrupts Ran/Crm1-dependent activities, presumably to prevent a host antiviral response. This finding implicates the Ran/Crm1 complex in the molecular pathogenesis of hepatitis B virus. Recently, we uncovered a new role of the Ran/Crm1 complex in regulating cellular proteins that control centrosome duplication and mitotic spindle assembly. We revealed nucleophosmin as a novel substrate for Ran/Crm1 to negatively regulate unnecessary centrosome duplication. In addition, we demonstrated a hepatitis B virus / HBx -dependent activation of RanBP1, a Ran-binding protein that is known to destabilize the Ran/Crm1 complex. Elevated RanBP1 is also observed in positive liver tissues and in hepatocellular carcinoma. Increased expression of RanBP1 leads to multipolar spindles and abnormal mitoses. Thus, the combined effects of hepatitis B virus / HBx contribute to chromosome instability. These findings led us to generate a new hypothesis in which the Ran/Crm1 complex serves as the centrosome duplication checkpoint by providing a loading dock mechanism that controls cellular homeostasis, and the disruption of this complex may result in genomic instability, which may be an early step in viral hepatitis-mediated hepatocarcinogenesis. In addition to HBx, recently we have completed a pilot study by determining hepatitis C virus core-related gene expression profiles in B lymphocytes. We found that hepatitis C virus core may evict immunity by selectively suppressing genes involved in antigen presentation. These studies are useful in dissecting viral activities that are essential in hepatocarcinogenesis. Furthermore, we have conducted molecular profiling studies to compare the gene expression changes in primary human hepatocytes infected with adenoviruses harboring HBx or hepatitis C virus structural or non-structural genes (p21CORE, NS3 or NS5A). We also compared these gene expression profiles to those obtained from hepatitis C virus -infected liver samples from chronic liver disease patients and hepatitis C virus -related hepatocellular carcinoma. We found that hepatitis C virus -related proteins largely induce unique genes when compared to HBx. In particular, interferon-inducible gene 27 was highly expressed in hepatitis C virus or core infected hepatocytes and hepatitis C virus -related chronic liver disease or hepatocellular carcinoma, but was less significantly expressed in HBx infected hepatocytes or hepatitis B virus-related chronic liver disease or hepatocellular carcinoma, indicating that interferon-inducible gene 27 may play a role in hepatitis C virus -mediated hepatocellular carcinoma. In conclusion, our results suggest that hepatitis B virus and hepatitis C virus promote hepatocellular carcinoma development mainly through different mechanisms.
期刊论文(7)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Cell cycle-dependent phosphorylation of nucleophosmin and its potential regulation by peptidyl-prolyl cis/trans isomerase.
核磷蛋白的细胞周期依赖性磷酸化及其通过肽基脯氨酰顺/反异构酶的潜在调节。
DOI:
--
发表时间:
2015
期刊:
Journal of molecular biochemistry
影响因子:
--
作者:
[Zhao,Xuelian, Ji,Junfang, Yu,Li-Rong, Veenstra,Timothy, Wang,XinWei]
通讯作者:
Wang,XinWei
DOI:
10.1126/sciadv.abq6978
发表时间:
2023-01-04
期刊:
SCIENCE ADVANCES
影响因子:
13.6
作者:
[Enose-Akahata, Yoshimi, Wang, Limin, Almsned, Fahad, Johnson, Kory R., Mina, Yair, Ohayon, Joan, Wang, Xin Wei, Jacobson, Steven]
通讯作者:
Jacobson, Steven
DOI:
10.1016/j.jhep.2009.12.025
发表时间:
2010-05
期刊:
Journal of hepatology
影响因子:
25.7
作者:
[Ji J, Zhao L, Budhu A, Forgues M, Jia HL, Qin LX, Ye QH, Yu J, Shi X, Tang ZY, Wang XW]
通讯作者:
Wang XW
DOI:
10.1016/j.ccell.2017.05.009
发表时间:
2017-07-10
期刊:
Cancer cell
影响因子:
50.3
作者:
[Chaisaingmongkol J, Budhu A, Dang H, Rabibhadana S, Pupacdi B, Kwon SM, Forgues M, Pomyen Y, Bhudhisawasdi V, Lertprasertsuke N, Chotirosniramit A, Pairojkul C, Auewarakul CU, Sricharunrat T, Phornphutkul K, Sangrajrang S, Cam M, He P, Hewitt SM, Ylaya K, Wu X, Andersen JB, Thorgeirsson SS, Waterfall JJ, Zhu YJ, Walling J, Stevenson HS, Edelman D, Meltzer PS, Loffredo CA, Hama N, Shibata T, Wiltrout RH, Harris CC, Mahidol C, Ruchirawat M, Wang XW, TIGER-LC Consortium]
通讯作者:
TIGER-LC Consortium
DOI:
10.1136/gutjnl-2014-307990
发表时间:
2015-05
期刊:
Gut
影响因子:
24.5
作者:
[Greten TF, Wang XW, Korangy F]
通讯作者:
Korangy F
Molecular signatures for liver cancer diagnosis and treatment stratification
-
批准号:10262066
-
项目类别:
-
资助金额:$190.21万
-
财政年份:--
-
负责人:Xin Wei Wang
-
依托单位:
Viral exposure signatures may define individuals vulnerable for COVID-19
-
批准号:10702767
-
项目类别:
-
资助金额:$25.47万
-
财政年份:--
-
负责人:Xin Wei Wang
-
依托单位:
Molecular signatures for liver cancer diagnosis and treatment stratification
-
批准号:10702334
-
项目类别:
-
资助金额:$200.12万
-
财政年份:--
-
负责人:Xin Wei Wang
-
依托单位:
The identification of human hepatocellular carcinoma metastasis genes
-
批准号:10926086
-
项目类别:
-
资助金额:$28.65万
-
财政年份:--
-
负责人:Xin Wei Wang
-
依托单位:
Mechanism of viral hepatitis-mediated hepatocarcinogenesis
-
批准号:10262018
-
项目类别:
-
资助金额:$17.29万
-
财政年份:--
-
负责人:Xin Wei Wang
-
依托单位:
The identification of human hepatocellular carcinoma metastasis genes
-
批准号:10262174
-
项目类别:
-
资助金额:$34.58万
-
财政年份:--
-
负责人:Xin Wei Wang
-
依托单位:
The role of cancer stem cells in liver cancer heterogeneity and subtypes
-
批准号:10262173
-
项目类别:
-
资助金额:$34.58万
-
财政年份:--
-
负责人:Xin Wei Wang
-
依托单位:
Roles of microbiota-mediated hepatocarcinogenesis
-
批准号:10702289
-
项目类别:
-
资助金额:$25.47万
-
财政年份:--
-
负责人:Xin Wei Wang
-
依托单位:
Identification of viral exposure signatures for early detection of liver cancer
-
批准号:10703084
-
项目类别:
-
资助金额:$18.19万
-
财政年份:--
-
负责人:Xin Wei Wang
-
依托单位:
Viral exposure signatures may define individuals vulnerable for COVID-19
-
批准号:10262566
-
项目类别:
-
资助金额:$69.17万
-
财政年份:--
-
负责人:Xin Wei Wang
-
依托单位:
The identification of human hepatocellular carcinoma metastasis genes
-
批准号:10702428
-
项目类别:
-
资助金额:$47.3万
-
财政年份:--
-
负责人:Xin Wei Wang
-
依托单位:
Molecular signatures for liver cancer diagnosis and treatment stratification
-
批准号:10925998
-
项目类别:
-
资助金额:$114.6万
-
财政年份:--
-
负责人:Xin Wei Wang
-
依托单位:
The role of cancer stem cells in liver cancer heterogeneity and subtypes
-
批准号:10926085
-
项目类别:
-
资助金额:$85.95万
-
财政年份:--
-
负责人:Xin Wei Wang
-
依托单位:
The role of cancer stem cells in liver cancer heterogeneity and subtypes
-
批准号:10702427
-
项目类别:
-
资助金额:$47.3万
-
财政年份:--
-
负责人:Xin Wei Wang
-
依托单位:
Viral exposure signatures may define individuals vulnerable for COVID-19
-
批准号:10487079
-
项目类别:
-
资助金额:$23.81万
-
财政年份:--
-
负责人:Xin Wei Wang
-
依托单位:
Identification of viral exposure signatures for early detection of liver cancer
-
批准号:10487275
-
项目类别:
-
资助金额:$17.01万
-
财政年份:--
-
负责人:Xin Wei Wang
-
依托单位:
海外基金